Simon F. Lacey

Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor

Ronald G. Collman, Michael C. Holmes, Colby R. Maldini, 2017, PLoS pathogens.

IMCT-15PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII+ GLIOBLASTOMA

Donald M. O'Rourke, Suyash Mohan, Eileen Maloney, 2015 .

RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

Anitha Rao, John J. Rossi, Shirley Li, 2010, Science Translational Medicine.

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Sasikanth Manne, John P. Reilly, Allison R. Greenplate, 2020, Science.

Ruxolitinib Prevents Cytokine Release Syndrome after CART Cell Therapy without Impairing the Anti-Tumor Effect in a Xenograft Model

Carl H. June, C. June, J. Melenhorst, 2016 .

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

David L. Porter, Adam Bagg, Wei-Ting Hwang, 2015, Science Translational Medicine.

Chimeric Antigen Receptor T Cells in Refractory B‐Cell Lymphomas

Stephen J. Schuster, David L. Porter, Jakub Svoboda, 2017, The New England journal of medicine.

Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions

Sasikanth Manne, John P. Reilly, Allison R. Greenplate, 2020, bioRxiv.